As of November 14, 2026, Shattuck Labs, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on June 2, 2026 (Form 8-K, June 2, 2026).
29 companies changed executives this week, 1 had other signals.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| ONITY GROUP INC. | announced the departure of its Chief Investment Officer | |
| Adicet Bio, Inc. | announced the departure of its Director | |
| MAMMOTH ENERGY SERVICES, INC. | announced the departure of its Chief Operating Officer | |
| CERENOME, INC. | named a new Director | |
| Cohen & Co Inc. | named a new Chief Executive Officer |
Sell to companies like Shattuck Labs, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Shattuck Labs, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-06-02. Every row below is cited to the filing it comes from, and this page adds each new change as Shattuck Labs, Inc. files it.
Layoffs on record: 1 filing or notice, latest 2024-10-01 (layoff filings and notices).
Also on the record for Shattuck Labs, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 27, 2026 | Stake report, Schedule 13G, by BlackRock, Inc. | 5.3% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by T. Rowe Price Investment Management, Inc. | 15.3% of the class | 5%+ stakes | Source |
| July 17, 2026 | Stake report, Schedule 13D/A, by Redmile Group, LLC | 9.9% of the class | 5%+ stakes | Source |
| June 17, 2026 | Stake report, Schedule 13G, by Deep Track Capital, LP | 5.17% of the class | 5%+ stakes | Source |
| June 15, 2026 | Stake report, Schedule 13D/A, by ORBIMED ADVISORS LLC | 9.99% of the class | 5%+ stakes | Source |
| June 11, 2026 | Stake report, Schedule 13D/A, by Redmile Group, LLC | 9.9% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by T. Rowe Price Investment Management, Inc. | 13.8% of the class | 5%+ stakes | Source |
| February 6, 2026 | Stake report, Schedule 13G, by T. Rowe Price Investment Management, Inc. | 11.7% of the class | 5%+ stakes | Source |
| November 13, 2025 | Stake report, Schedule 13G/A, by Prosight Management, LP | 9.9% of the class | 5%+ stakes | Source |
| September 2, 2025 | Stake report, Schedule 13D, by ORBIMED ADVISORS LLC | 9.99% of the class | 5%+ stakes | Source |
| August 26, 2025 | Stake report, Schedule 13D/A, by Redmile Group, LLC | 9.9% of the class | 5%+ stakes | Source |
| August 6, 2025 | Stake report, Schedule 13D/A, by Redmile Group, LLC | 11.8% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Shattuck Labs, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Shattuck Labs, Inc. and the records around it.
Shattuck Labs, Inc. elsewhere on the record
- 5%+ stake filings Oct 2026
- Who owns it
Companies that share a holder
- Prosight Management, LP also filed stake reports on 5 other companies: ADC Therapeutics SA (Nov 2026), Janux Therapeutics, Inc. (Nov 2026), OnKure Therapeutics, Inc. (Aug 2026)
- Redmile Group, LLC also filed stake reports on 18 other companies: FATE THERAPEUTICS INC (Nov 2026), Electra Therapeutics, Inc. (Sep 2026), Neurogene Inc. (Aug 2026)
- ORBIMED ADVISORS LLC also filed stake reports on 38 other companies: Aspen Neuroscience, Inc. (Nov 2026), ArriVent BioPharma, Inc. (Oct 2026), ADARx Pharmaceuticals, Inc. (Oct 2026)
Watch Shattuck Labs, Inc.
Get an email when Shattuck Labs, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Shattuck Labs, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Shattuck Labs, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Shattuck Labs, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
14 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 14 records.
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-06-02 | Reported | not named in the filing | 8-K, 2026-06-02 |
New leaders reset buying decisions — get the Full Report on Shattuck Labs, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at Shattuck Labs, Inc., with the record behind each one.
Find candidates like senior executive at Shattuck Labs, Inc.Every change, in the filing's words
Reported
Departure of Director or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
- At the Annual Meeting, the Company's stockholders approved an amendment and restatement of the Company's 2020 Equity Incentive Plan (as so amended, the "Plan") to revise the calculation of the automatic annual increase in the number of shares of common stock available for issuance, increase the number of shares available for issuance under the Plan by 1,691,082 shares, and extend the Plan's term to March 23, 2036.
Tools for this story
Each opens in a new tab, filled in for Shattuck Labs, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.
